SPARC

Sun Pharma Advanced Research Company Limited

Source: NSE · Updated 4 Nov, 11:32 pm IST

Filed 2 Nov, 07:46 pm IST Q2 FY27 (Sep ’26)Consolidated₹ lakhs

Revenue

3,003

▲ 282.1% vs Q2 FY26

Operating profit (EBITDA, derived from filing)

-4,561

vs Q2 FY26: n/a

Net profit

-2,439

vs Q2 FY26: n/a

EPS (₹)

-0.75

vs Q2 FY26: n/a

Operating margin

-151.9%

+68420 bps vs Q2 FY26

Net margin

-81.2%

+88380 bps vs Q2 FY26

Loss narrowed vs Q2 FY26

Revenue+282% vs Q2 FY26 · −25% vs Q1 FY27

ProfitLoss narrowed vs Q2 FY26 · Loss widened vs Q1 FY27

View official filing ↗

Numbers from the company's structured XBRL filing on NSE, cross-checked with P&L totals.

Quarter comparison

Item	Q2 FY27 (Sep ’26)	Q1 FY27 (Jun ’26)	vs Q1 FY27	Q2 FY26 (Sep ’25)	vs Q2 FY26
Revenue from operations	3,003	3,992	▼ 24.8%	786	▲ 282.1%
Other income	2,362	2,366	▼ 0.2%	1	▲ 236100.0%
Total income	5,365	6,358	▼ 15.6%	787	▲ 581.7%
Total expenses	7,796	8,425	▼ 7.5%	8,366	▼ 6.8%
Operating profit (EBITDA)*	-4,561	-3,400	—	-6,572	—
Profit before tax	-2,431	-2,067	—	-7,579	—
Tax expense	8	11	▼ 27.3%	6	▲ 33.3%
Net profit	-2,439	-2,078	—	-7,585	—
EPS (₹)	-0.75	-0.64	—	-2.34	—
Operating margin	-151.9%	-85.2%	−6670 bps	-836.1%	+68420 bps
Net margin	-81.2%	-52.1%	−2910 bps	-965.0%	+88380 bps

Showing Q2 FY27 (Sep ’26) and change vs Q2 FY26. Turn your phone sideways for Q1 FY27 (Jun ’26).

Figures in ₹ lakhs except EPS. Consolidated figures from the company's XBRL filing on NSE. Each row is shown only if it reconciles with the others (e.g. PBT − tax = net profit); rows we couldn't verify are left out. Net margin = net profit ÷ revenue. *Operating profit (EBITDA), derived from the filing: profit before exceptional items and tax + finance costs + depreciation − other income. Operating margin = EBITDA ÷ revenue.

All Sun Pharma Advanced Research Company results, dividends & filings ›

Other results filed 2 Nov

HAPPSTMNDS Happiest Minds Technologies Limited›DIGITIDE Digitide Solutions Limited›LLOYDSENGG LLOYDS ENGINEERING WORKS LIMITED›NATIONALUM National Aluminium Company Limited›SADBHIN Sadbhav Infrastructure Project Limited›FLAIR Flair Writing Industries Limited›KEC KEC International Limited›CHOICEIN Choice International Limited›VENTIVE Ventive Hospitality Limited›WALCHANNAG Walchandnagar Industries Limited›SIGNPOST Signpost India Limited›IDEAFORGE Ideaforge Technology Limited›

Today's results ›

SUN PHARMA ADVANCED RESEARCH COMPANY Q2 FY27 ; NET LOSS OF ₹24 CR VS LOSS ₹76 CR (YOY), LOSS ₹21 CR (QOQ)

REVENUE UP 282% AT ₹30 CR (YOY), DOWN 25% (QOQ)

EBITDA LOSS OF ₹46 CR VS LOSS ₹66 CR (YOY), LOSS ₹34 CR (QOQ)

MARGINS AT -151.9% VS -836.1% (YOY), -85.2% (QOQ)

https://resultkal.com/r/sparc-2026-11-02
Source: NSE filing · not investment advice

FAQ

When did Sun Pharma Advanced Research Company announce Q2 FY27 results?

Sun Pharma Advanced Research Company filed its results on NSE on 2 Nov, 07:46 pm IST.

What does QoQ and YoY mean?

QoQ compares with the previous quarter; YoY compares with the same quarter last year. Growth is calculated from the figures in the filing.

Are these Sun Pharma Advanced Research Company figures official?

They are auto-read from the company's NSE filing and may contain errors. Always confirm with the official PDF linked on this page.

Explore

Today's results Results this week Q2 FY27 results dates Dividend stocks this week Bonus issue 2026 Stock split 2026

Figures are auto-read from the company's NSE filing and may contain errors. Check the official filing before deciding. Not investment advice.

← SPARC overview